Wave Life Sciences Ltd. (NASDAQ: WVE) on Friday, plunged -4.38% from the previous trading day, before settling in for the closing price of $5.94. Within the past 52 weeks, WVE’s price has moved between $3.50 and $7.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 610.91% over the last five years. The company achieved an average annual earnings per share of -95.47%. With a float of $98.75 million, this company’s outstanding shares have now reached $119.16 million.
The firm has a total of 268 workers. Let’s measure their productivity.
Wave Life Sciences Ltd. (WVE) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Wave Life Sciences Ltd. is 20.83%, while institutional ownership is 75.31%. The most recent insider transaction that took place on Aug 21 ’24, was worth 279,555. In this transaction President and CEO of this company sold 48,366 shares at a rate of $5.78, taking the stock ownership to the 359,059 shares. Before that another transaction happened on Aug 21 ’24, when Company’s Officer proposed sale 48,366 for $5.78, making the entire transaction worth $279,638.
Wave Life Sciences Ltd. (WVE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -95.47% per share during the next fiscal year.
Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators
Wave Life Sciences Ltd. (WVE) is currently performing well based on its current performance indicators. A quick ratio of 0.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd. (WVE)
Analysing the last 5-days average volume posted by the [Wave Life Sciences Ltd., WVE], we can find that recorded value of 0.72 million was lower than the volume posted last year of 0.81 million. As of the previous 9 days, the stock’s Stochastic %D was 48.36%. Additionally, its Average True Range was 0.33.
During the past 100 days, Wave Life Sciences Ltd.’s (WVE) raw stochastic average was set at 54.89%, which indicates a significant decrease from 57.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.30% in the past 14 days, which was higher than the 68.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.84, while its 200-day Moving Average is $5.45. Now, the first resistance to watch is $5.91. This is followed by the second major resistance level at $6.13. The third major resistance level sits at $6.25. If the price goes on to break the first support level at $5.57, it is likely to go to the next support level at $5.45. Now, if the price goes above the second support level, the third support stands at $5.23.
Wave Life Sciences Ltd. (NASDAQ: WVE) Key Stats
Market capitalization of the company is 708.52 million based on 122,475K outstanding shares. Right now, sales total 113,310 K and income totals -57,510 K. The company made 19,690 K in profit during its latest quarter, and -32,920 K in sales during its previous quarter.
